LBA85 REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer

• DOI: 10.1016/j.annonc.2020.08.2327
• Publication Date: 2020-09-22T09:19:54Z
• Authors: B. Besse; J. Menis; P. Bironzo; R. Gervais; L. Greillier; I. Monnet; L. Livi; R. Young; C. Decroisette; N. Cloarec; G. Robinet; R. Schott; R. Califano; F. De Marinis; G.L. Banna; M. Mauer; A. Pochesci; B. Hasan; T. Berghmans; A-M.C. Dingemans
• Keywords: Clinical endpoint; Carboplatin